Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hamlet Pharma Year-end Report July 2022 – June 2023

Hamlet Pharma Hamlet Pharma is developing an entirely new class of anti-cancer therapeutics for multiple cancer indications based on the discovery of its proprie- tary drug complex HAMLET (‘Human Alpha-lactal- bumin Made Lethal to Tumor cells’). HAMLET is derived from the human breast milk protein, alpha- lactalbumin, and represents a groundbreaking therapeutic solution with high tumor-killing capac- ity, high target specificity, killing >40 different types of tumor cells and no demonstrated toxicity. As such, it has the potential to revolutionize cancer treatment. Hamlet Pharma is now

Normet Group Oy has published its Q2 2023 Interim Report

NORMET GROUP OY PRESS RELEASE 28 AUGUST 2023 AT 10:00 AM EEST Normet Group Oy has published its Q2 2023 Interim Report Normet Group Oy has published its Interim Report for 1 April – 30 June 2023 on Monday 28 August 2023. The report is available on www.normet.com.  For more information, please contact: Ville Pasanen, CFO, Normet Group OyPhone: +358 40 555 8555E-Mail: ville.pasanen@normet.com  Normet is a world-leading, innovative technology company. We define the future of underground operations in mining, tunnelling, and civil engineering projects, helping our partners

Fazer delivers the taste of Christmas

Sweets are an integral part of Finnish Christmas celebrations. During the holidays, people indulge more in chocolate, marmalades, and sugar confectionery than in their daily life, and pralines and other more high-end sweets are often given as gifts. Sweet selections for Christmas highlight locality and traditional products and brands, but people are also keen to try new products. Fazer’s selection of pralines features many beloved high-quality flavours familiar from years ago, but also this season's charming new products, such as the smooth Karl Fazer Silky Vanilla and Finlandia chocolate

SCA becomes wholly owner of Gällö Timber AB

SCA and Persson Invest began their collaboration around Gällö Timber and the sawmill in Gällö, Jämtland in 2010. Since 2010, significant investments have been made in the sawmill to develop its operations and strengthen its competitiveness. Today, the sawmill has 115 employees and a capacity of 370,000 cubic meters of sawn timber.SCA is Europe's largest private forest owner with 2.7 million hectares and, with its forest holdings at its core, has developed a well-invested industrial operation with sawmills, pulp mills, and manufacturing of packaging paper. By acquiring Persson Invest's share

Senegalese power plant opts for Wärtsilä long-term service agreement to ensure supply reliability

Wärtsilä Corporation, Trade press release, 28 August 2023 at 10 AM EESTTechnology group Wärtsilä has signed a long-term service agreement for two years with ContourGlobal, a global energy provider based in the U.S. The agreement covers the company’s Cap des Biches power plant  in Dakar, Senegal. The plant dispatches power to the national electricity distributor Senelec, and reliability of supply is essential. The Wärtsilä agreement is designed to ensure that the customer’s commercial and

BioStock: The pieces fell into place for Dicot in Q2

Uppsala-based Dicot continues to take decisive steps in the development of LIB-01. The phase I study with the drug candidate has now started. In the latest quarterly report, CEO Elin Trampe expresses her enthusiasm for the milestone. BioStock took the opportunity to contact Trampe in connection with the report for her view on the autumn.Read the full article at biostock.se : https://www.biostock.se/en/2023/08/the-pieces-fell-into-place-for-dicot-in-q2-ceo/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Repurchase of Truecaller B shares in week 34, 2023

During 21 August 2023 and 25 August 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 596,488 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 7 June 2023. The share buyback programme will run between 7 June up until the 2024 AGM which will be held in May 2024, and is carried out in accordance “Emittentregelverket”.   On the Annual General Meeting 2023 the Board was authorized to buy back B-shares up until

Cereno Scientific’s drug candidate CS585 published in top-tier journal Blood with favorable preclinical data on prevention of thrombosis

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that a publication concerning drug candidate CS585 has been published in the top peer-reviewed medical journal Blood. The publication shows that CS585, a prostacyclin receptor agonist, is a highly potent and selective compound given both orally and intravenously and prevents thrombosis for up to 48 hours as observed in preclinical studies.The publication titled “The oxylipin analogue CS585 prevents platelet activation and thrombosis through

Share buy-back programme status

Company announcement no. 17/202328 August 2023   The board of directors initiated a share buy-back programme on 28 June 2023 to be conducted in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules (see company announcement 11/2023 ). Under this programme Wirtek will acquire up to a total of 60,000 shares, corresponding to 0.78% of

Save the date: Beijer Ref is organising a Capital Markets Day on November 30, 2023

Beijer Ref invites investors, analysts, media, and other key stakeholders to the company's Capital Markets Day, which will take place physically in Stockholm and will be live streamed online. The event will be hosted at Epicenter (Disruption Hall), Mäster Samuelsgatan 36, in Stockholm. The Capital Markets Day will include updates on Beijer Ref's strategy, financial goals, priorities, and the company's efforts towards sustainability. More information regarding the agenda and registration link will be provided closer to the event. For more information, please contact:Niklas

Valmet to deliver seventh tissue production line to Papel San Francisco in Mexico

Valmet Oyj’s press release on August 28, 2023 at 9:30 a.m. EESTValmet will supply an Advantage DCT 100TS tissue production line to Papel San Francisco in Mexico. The new TM 10 machine will be installed at the company's mill in Mexicali and the start-up is planned for the second quarter 2025. The order was included in Valmet's orders received of the second quarter 2023. The value of the order will not be disclosed. Papel San Francisco currently has five Valmet lines in operation, started up between 2006 and 2020. TM 9 is currently under delivery and will start up in 2024. The upcoming

TagMaster, through its US subsidiary Sensys Networks, acquires the radar division of Image Sensing Systems

Press release, Stockholm, Sweden, August 28, 2023 TagMaster, a leading supplier of data solutions and advanced sensor systems for Smart Cities within Traffic and Rail, through its US subsidiary Sensys Networks, has signed an agreement to acquire the radar division of Image Sensing Systems, Inc. (ISS), a Minnesota, US, corporation. The purchase price is approximately USD 4.8 million on a debt- and cash-free basis.   ISS is a wholly-owned subsidiary of Autoscope Technologies Corporation (OTCQX: AATC) and a leading provider of video and radar vehicle detection and traffic data solutions

Industry CEO joins Haeger & Carlsson to lead Nordic expansion

Haeger & Carlsson (H&C) has recruited Helena Strigård as Chief Executive Officer and partner to lead the company's journey of expansion into the Nordic market. The mission is to become the leading player in executive search and interim services within life science in the Nordics. Helena comes most recently from the role of CEO at the pharmaceutical manufacturer NorthX Biologics and was previously the CEO of the industry organization SwedenBIO. Rolf Carlsson, who co-founded the company with Gunilla Haeger, will thus take on a new role in the company as Chairman of the Board and business

Collective Minds Radiology announces closing of SEK 84m financing, led by Segulah Medical Acceleration and existing shareholders

Collective Minds Radiology, a fast-growing, Swedish health-tech company with a mission to build the world’s largest platform and community for healthcare collaboration, announces the closing of a SEK 84 million funding round. The round was led by Segulah Medical Acceleration (“SMA”), a Scandinavia-based life science-focused investment company, together with existing shareholders, Brightly Ventures, Tradecity, Crista Galli Ventures and several European business angels. The funding will enable Collective Minds to accelerate the commercial expansion of its professional healthcare collaboration

BioStock: Invent Medic signs distribution agreement in Australia

Spotlight-listed Invent Medic has recently taken further steps in the company’s market expansion. Together with the newly appointed distribution partner Pelvic Floor Exercises, the company will market Efemia Bladder Support in Australia. BioStock contacted CEO Anna Lindström for a comment.Read the full article at biostock.se: https://www.biostock.se/en/2023/08/invent-medic-signs-distribution-agreement-in-australia/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

XNK Therapeutics to present at the 8th CAR-TCR Summit in Boston

XNK Therapeutics AB (“XNK”) today announced that Linda Brick, Head of QA, will be speaking at the 8th CAR-TCR Summit in Boston.The annual CAR-TCR Summit is the world’s pre-eminent industry-leading comprehensive forum that unites the global cell therapy community across a variety of cell types (αβ T, γδ T, NK, NKT, Macrophage, TIL and more), Over 1000 experts from both pharmaceutical companies, including autologous and allogeneic cell therapy drug developers, and academia participate to advance the field. On August 30, Linda Brink will present XNK and talk about improving training and

XACT OMXC25 – Sustainability alignment and name change

We will be changing the fund rules for the XACT OMXC25 exchange-traded fund (UCITS ETF) on 1 September 2023.   Change to a sustainability indexThe fund will be switching to an index that has sustainability requirements for the companies included in the index. This does not result in any substantial changes to the fund’s investment focus or risk level, nor does it lead to any additional costs for you. In conjunction with the switch to a sustainability index, the fund will transition from a so-called Article 6 fund to one that will be reported as an Article 8 fund pursuant to SFDR [1].

Eltel signs one-year agreement with Telia in Finland worth about EUR 30 million

Eltel Finland has entered into a one-year extension of its ongoing delivery agreement with Telia Finland, covering fixed and mobile telecom services. The agreement is worth about EUR 30 million.Through this agreement, Eltel continues to be Telia’s partner for a wide range of telecom services, including 5G rollout, fixed and mobile networks construction, installation and maintenance. The extension will be in effect for one year, beginning on 1 April 2024. For further information:Juha Luusua, Managing Director, Eltel FinlandPhone: +358 40 311 3005, juha.luusua@eltelnetworks.com Elin

(Retransmission) Vetiqure AB, the Animal care division of Scandinavian ChemoTech and Royal Veterinary College, to establish a Centre of Excellence for TSE

Retransmission of press release that was issued on August 26, 2023 at 11:30 CET. Following a  six-month evaluation,  the Royal Veterinary College (RVC) will now aquire the vetIQure™ system and make Tumour Specific Electroporation (TSE) one of the standard therapies offered by RVC Equine.  This equipment will be funded by the RVC Animal Care Trust. Vetiqure and the RVC are planning to establish a Centre of Excellence for the TSE technology.During the trials, the equine team, led by Drs. Michael Hewetson and Andy Fiske-Jackson, has evaluated the TSE on patients suffering from both

NEW CFO APPOINTED

Stockholm, August 28th, 2023 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Richard Hallström as a Chief Financial Officer (CFO), effective today 28th of August. He succeeds Markus Hökerberg, who has acted as an Interim CFO. Mr. Hallström previously served as CFO at ScandiNova Systems and prior to his time at ScandiNova Systems, he held several leadership roles as CFO, Finance Director and Finance Manager at Global Stoneridge Electronics and Tyco Healthcare Norden AB. He received a bachelor’s degree in business administration

Elkem launches UV Hg and UV LED curable silicone solutions for sustainable release coatings.

Elkem launches SILCOLEASE[TM] UV POLY 126 a new “Ready-To-Use” UV acrylate formulation especially designed for release coating of thermal labels that are self-wound without the use of a separate release liner. It guarantees the desired level of performance during the manufacturing, cutting, converting and printing stages, making it possible to develop sustainable thermal printed linerless labels and enable a circular economy.Elkem is one of the world’s leading suppliers of silicon-based advanced material solutions shaping a better and more sustainable future. Elkem is committed to develop

TF Bank AB (publ) plans to issue AT1 bonds

TF Bank AB (publ) (“TF Bank”) has mandated Nordea to evaluate the possibility to issue AT1 bonds of SEK 100-150 million to optimise the capital structure and facilitate future growth. The bonds will have a perpetual tenor with the first call option after five years. The transaction is expected to take place in the near future, subject to market conditions. Nordea acts as bookrunner and Gernandt & Danielsson as legal counsel in relation to the planned transaction. For further information, please contact:Mikael Meomuttel, CFO and Head of Investor Relations +46 (0) 70 626 95 33 The

Veidekke: Exercise of employee share options in Veidekke ASA

A total of 22 participants in the Company's share option program have on August 25th 2023, exercised a total of 10 325 options at a strike price of NOK 43.05.A total of 82 participants in the Company's share option program have on August 25th 2023 exercised a total of 67 270 options at a strike price of NOK 47.36. Shares acquired through the program have a sales restriction on one year after exercise date. Following the exercise, the employees will purchase 77 595 shares. These shares will be transferred September/October 2023. 1 500 options have been exercised by primary insiders.

MindArk Interim Report Q2 2023

MindArk PE AB (publ) ("MindArk", the "Company") hereby announces that the Company's interim report for Q2 2023 has been published.Comment from CEO Henrik Nel Jerkrot:"During the second quarter of 2023, we increased our turnover by 28% compared to the same period last year, while also having executed an internal reorganization within the company. However, the reorganization involves a reservation of a one-time cost of 14 million SEK, which affects our net profit for Q2 results but positions MindArk well for the future, with an increased focus on innovation and growth in the digital world.

There are no items matching the current filter
There are no more items matching the current filter
Back to top